The first and only 2 gm meropenem in KSA

Ultra- broad spectrum antibiotic

• Highly resistant to Beta lactamase and cephalosporinase

• Effective against mixed infections

• Exhibits better efficacy rate (95.5%) as compared to lmipenem / Cilastatin (76. 7%) in

treatment of moderate to severe intra- abdominal infections *

indications for 2gm Meropenem

• Broncho – pulmonary infections in cystic fibrosis patients

• Acute bacteria meningitis as Meropenem ex ibit less neurotoxicity than lmipenem/Cilastatin,

which is contraindicated in patients with active ce1ral nervous system disease or injury **

Storage after reconstit~tion

Prepared solution can be stored up to 12 hrs under refrigerated conditions (2-8 c)

Ref.

*Clin Microbiol Infect. 2000 Jun;6(6):294-302. doi: 10.1046/j.1469-0691 .2000.00082.x.

** Philip S. Barie, … Marc J. Shapiro, in Current Therapy of Trauma and Surgical Critical

Care (Third Edition), 2024